Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: A combined analysis of 3 pivotal, randomised, phase 3 trials

Autor: Lipton, Allan, Fizazi, Karim, Stopeck, Alison T., Henry, David H., Brown, Janet E., Yardley, Denise A., Richardson, Gary E., Siena, Salvatore, Maroto, Pablo, Clemens, Michael, Bilynskyy, Boris, Charu, Veena, Beuzeboc, Philippe, Rader, Michael, Viniegra, Maria, Saad, Fred, Ke, Chunlei, Braun, Ada, Jun, Susie
Zdroj: In European Journal of Cancer November 2012 48(16):3082-3092
Databáze: ScienceDirect
Externí odkaz: